Legal Opinion

In re Skelaxin (Metaxalone) Antitrust Litigation

United States Judicial Panel on Multidistrict Litigation

Decided April 17, 2012No. MDL No. 2343PublishedCited by 2 opinions

1Opinion of the Court

*1351TRANSFER ORDER

KATHRYN H. YRATIL, Acting Chairman.

Before the Panel:* Pursuant to 28 U.S.C. § 1407, plaintiffs in the Eastern District of Tennessee Johnson’s Village Pharmacy action move to centralize this litigation in the Eastern District of Tennessee. This litigation currently consists of two actions pending in the Eastern District of Pennsylvania and an action in the Eastern District of Tennessee, as listed on Schedule A. The cases in this litigation involve allegations that Defendants King Pharmaceuticals, Inc. (King) and Mutual Pharmaceutical Company, Inc. (Mutual) violated federal and…

2Cases cited2 opinions

  1. In Re: Oxycontin Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2008
  2. In Re Pineapple Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2004

3Cited by2 opinions

  1. In re Generic Drug Pricing Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016
  2. In re Ranbaxy Generic Drug Application Antitrust Litig.United States Judicial Panel on Multidistrict Litigation · 2019

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API